Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers

Autor: Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F. Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C. Freitas, Ricardo Armisén

Publikováno v: BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)

Abstract Background Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10–20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung Cancer (NSCLC) there are clear differences in bot

Externí odkaz: https://doaj.org/article/299f116c68364c9a8cb95e5dde0ba0e8

Characteristics and long‐term outcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP)

Autor: Leonardo Rojas, Andrés F. Cardona, Rogelio Trejo‐Rosales, Zyanya Lucia Zatarain‐Barrón, Laura‐Alejandra Ramírez‐Tirado, Alejandro Ruiz‐Patiño, Saúl Campos Gómez, Luis Corrales, George Oblitas, Ludwing Bacon, Claudio Martín, Vladmir C. Cordeiro de Lima, Helano C. Freitas, Luis Mas, Carlos Vargas, Hernán Carranza, Jorge Otero, María Angelina Pérez, Lisde González, Luis Chirinos, Sara T. Granados, July Rodriguez, Renata Báez, Yuly‐Andrea Remolina Bonilla, Gustavo Núñez Cerrillo, Pilar Archila, Mauricio Cuello, Niki Karachaliou, Rafael Rosell, Oscar Arrieta, on behalf CLICaP

Publikováno v: Thoracic Cancer, Vol 10, Iss 3, Pp 508-518 (2019)

Background Malignant pleural mesothelioma (MPM) is an aggressive tumor, associated with poor prognosis. There is a lack of information about the clinical and pathological features related with survival in the Latin American population. Methods The Me

Externí odkaz: https://doaj.org/article/93c845431c264d96b3a14c9c85798817

Characteristics and outcomes of thymomas in Latin America: results from over 10 years of experience (CLICaP-LATimus)

Autor: C. Sotelo, Rossana Ruiz, Vladmir Cláudio Cordeiro de Lima, Florencia Tsou, S. Lozano, CLICaP, Pilar Archila, Patricia Rioja, Luisa Ricaurte, Marcelo Corassa, Oscar Arrieta, Alejandro Ruiz-Patiño, Camila Ordóñez-Reyes, Ana Karina Patané, Andrés F. Cardona, Luis Corrales, T. Soria, July Rodriguez, L. Rojas, Feliciano Barrón, Rafael Rosell, J. Ávila, Luis Mas, Zyanya Lucia Zatarain-Barrón, Helano C. Freitas, Claudio Martin, Carmen Puparelli, Jordi Remon, Mauricio Cuello, Diego Enrico

Publikováno v: Thoracic Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Thoracic Cancer, Vol 12, Iss 9, Pp 1328-1335 (2021)
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque

Background Thymomas are a group of rare neoplasms of the anterior mediastinum. The objective of this study was to describe the demographics, clinical characteristics and treatment approaches in Latin America. Methods This was a retrospective multicen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5aead9f8b5d14288e0fd4612422b3fb
http://europepmc.org/articles/PMC8088938

The diffuse-type gastric cancer epidemiology enigma

Autor: Williams Fernandes Barra, Moyses Szklo, M. Constanza Camargo, Geraldo Ishak, Paulo Pimentel Assumpção, Emmanuel Dias-Neto, Luiz Gonzaga Vaz Coelho, Helano C. Freitas, Felipe José Fernandez Coimbra

Publikováno v: BMC Gastroenterology, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Gastroenterology

Background Intestinal and diffuse gastric adenocarcinomas differ in clinical, epidemiological and molecular features. However, most of the concepts related to the intestinal-type are translated to gastric adenocarcinoma in general; thus, the peculiar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0fd7eb24eca7831adda307ac11b3fbb
http://link.springer.com/article/10.1186/s12876-020-01354-4

ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer

Autor: Filippo de Marinis, Helano C. Freitas, Yi-Long Wu, David Vicente, Gee-Chen Chang, Mariano Provencio, Nicolaas A. Bakker, J. Rigas, Sang We Kim, Qing Zhou, Liyan Jiang, Parneet Cheema, Gilberto de Castro, Claudio Martin, Giulio Metro, Byoung Chul Cho, Miguel F. Miranda, Johan Vansteenkiste, Yuh Min Chen

Publikováno v: Future Oncology. 15:3003-3014

Aim: Osimertinib is a third-generation, irreversible, oral EGFR tyrosine kinase inhibitor. We report real-world effectiveness and safety data. Patients & methods: EGFR T790M positive advanced non-small-cell lung cancer adults, who received ≥1 prior

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::070afa5c54ebac0e10a2cd5be009d4b0
https://doi.org/10.2217/fon-2019-0324